Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with CancerDavid J. Pinato, Javier Marco‐Hernández, Alberto Zambelli et al.|Cancer Discovery|2020Cited by 183
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry studyDavid J. Pinato, David García-Illescas, Josep Tabernero et al.|The Lancet Oncology|2021Cited by 136
Time-Dependent COVID-19 Mortality in Patients With CancerOnCovid study group, Ariadna Roqué, David J. Pinato et al.|JAMA Oncology|2021Cited by 72
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European studyDavid J. Pinato, Yien Ning Sophia Wong, Lorenza Scotti et al.|European Journal of Cancer|2021Cited by 51
Clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world dataHelen-Cara Younan, Debra H. Josephs, Alex Giorgiou et al.|Lung Cancer|2022Cited by 0